A Placebo-controlled Double-blind Parallel-Group Bayesian Adaptive Randomization Design and Dose Regimen-finding Study to Evaluate Safety Tolerability and Efficacy of BAN2401 in Subjects with Early Alzheimer's Disease
-
- STATUS
- Not Recruiting
Summary
The purpose of this research is to find out if the study drug has a benefit on a person?s cognitive status via a series of specialized cognitive tests. The purpose of this research is also to find out if this study drug is safe and well-tolerated in people with early Alzheimer?s disease.
Description
The purpose of this research is to find out if the study drug has a benefit on a person?s cognitive status via a series of specialized cognitive tests. The purpose of this research is also to find out if this study drug is safe and well-tolerated in people with early Alzheimer?s disease.
Details
| Condition | Alzheimer's disease |
|---|---|
| Age | 50years - 90years |
| Clinical Study Identifier | TX6494 |
| Last Modified on | 19 February 2024 |
Similar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.